In the former case, the receptor is expressed by infiltrating neutrophils in chronic obstructive pulmonary disease (COPD) with inhibition of CXCR2-mediated inflammatory responses effective in attenuating lung damage [15]. This evidence concerns the gene CXCR2 and chronic obstructive pulmonary disease.